The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis
Abstract
Purpose: The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult. Methods: The present review surveys the molecular mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addition to relationships between glioma cell migration and resistance to apoptosis in terms of the molecular signaling pathways. Results: Clinical and experimental data demonstrate that glioma cell migration is a complex combination of multiple molecular processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton. Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern PI3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II). Conclusion: A number of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults. However, these pathways are not all constitutively activated at the same time in any one glioma. Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the molecular profiling of their tumors before undergoing any treatment to combat their migratory glioma cells. Specific antimigratory compounds should be added to conventional radio- and/or chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Cell Migration: Integrating Signals from Front to Back
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., Parsons, J. T., & Horwitz, A. R. (2003) · Science · doi:10.1126/science.1092053 · Cited by 4,978
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Cell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness
Palecek, S. P., Loftus, J. C., Ginsberg, M. H., Lauffenburger, D. A., & Horwitz, A. F. (1997) · Nature · doi:10.1038/385537a0 · Cited by 1,427
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
Giese, A., Bjerkvig, R., Berens, M. E., & Westphal, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.063 · Cited by 1,200
Rho GTPases and cell migration
Ridley, A. J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.15.2713 · Cited by 1,191
Pytela, R., Pierschbacher, M. D., & Ruoslahti, E. (1985) · Cell · doi:10.1016/0092-8674(85)90322-8 · Cited by 1,101
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0382 · Cited by 1,079
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
An alternative, nonapoptotic form of programmed cell death
Sperandio, S., de Belle, I., & Bredesen, D. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14376 · Cited by 1,006
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847
Sekulić, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., & Abraham, R. T. (2000) · PubMed · Cited by 710
Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement
Parsons, J. T., Martin, K. H., Slack, J. K., Taylor, J. M., & Weed, S. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203877 · Cited by 672
Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins
Couet, J., Sargiacomo, M., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30429 · Cited by 664
CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration
Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., & Cheresh, D. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.961 · Cited by 659
Juliano, R. L. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.090401.151133 · Cited by 597
Na+/K+‐ATPase as a signal transducer
Xie, Z., & Askari, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02910.x · Cited by 592
Primary and secondary glioblastomas: From concept to clinical diagnosis
Kleihues, P., & Ohgaki, H. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.1.44 · Cited by 586
Paxillin: a focal adhesion-associated adaptor protein
Schaller, M. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204786 · Cited by 541
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
Bellail, A. C., Hunter, S. B., Brat, D. J., Tan, C., & Van Meir, E. G. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.013 · Cited by 526
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Inbal, B., Bialik, S., Sabanay, I., Shani, G., & Kimchi, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109094 · Cited by 477
Focal adhesions: Structure and dynamics
Petit, V., & Thiery, J. (2000) · Biology of the Cell · doi:10.1016/s0248-4900(00)01101-1 · Cited by 392
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
Chakravarti, A., Zhai, G., Suzuki, Y., Sarkesh, S., Black, P. M., Muzikansky, A., & Loeffler, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.193 · Cited by 377
Yang, L., Dan, H. C., Sun, M., Liu, Q., Sun, X.-M., Feldman, R. I., Hamilton, A. D., Polokoff, M., Nicosia, S. V., Herlyn, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0343 · Cited by 371
Haas, M., Askari, A., & Xie, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002951200 · Cited by 363
McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z., & Newman, R. A. (2000) · PubMed · Cited by 304
Cho, S. Y., & Klemke, R. L. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.1.223 · Cited by 269
Reardon, D. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1389 · Cited by 255
Defective E-cadherin/catenin complexes in human cancer
Van Aken, E., De Wever, O., da Rocha, C. A., & Mareel, M. (2001) · Virchows Archiv · doi:10.1007/s004280100516 · Cited by 250
Desai, B. N., Myers, B. R., & Schreiber, S. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261702698 · Cited by 248
Targeted Molecular Therapy of GBM
Mischel, P. S., & Cloughesy, T. F. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00006.x · Cited by 247
Knobbe, C. B., & Reifenberger, G. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00481.x · Cited by 238
Beliën, A. T. J., Paganetti, P. A., & Schwab, M. E. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.373 · Cited by 234
Hall, C. L., Wang, C., Lange, L. A., & Turley, E. A. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.575 · Cited by 231
Actin, microtubules and focal adhesion dynamics during cell migration
Wehrle-Haller, B., & Imhof, B. A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00071-7 · Cited by 225
Characterization of integrin receptors in normal and neoplastic human brain.
Paulus, W., Baur, I., Schuppan, D., & Roggendorf, W. (1993) · PubMed · Cited by 217
CD44 mediates human glioma cell adhesion and invasion in vitro.
Merzak, A., Koochekpour, S., & Pilkington, G. J. (1994) · PubMed · Cited by 212
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
Wang, H., Wang, H., Zhang, W., Huang, H. J., Liao, W. S. L., & Fuller, G. N. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700123 · Cited by 212
Migration of Human Glioma Cells on Myelin
Giese, A., Kluwe, L., Laube, B., Meissner, H., Berens, M. E., & Westphal, M. (1996) · Neurosurgery · doi:10.1097/00006123-199604000-00026 · Cited by 210
Small-Molecule Inhibitors of Actin Dynamics and Cell Motility
Fenteany, G., & Zhu, S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452348 · Cited by 208
Camby, I., Belot, N., Lefranc, F., Sadeghi, N., de Launoit, Y., Kaltner, H., Musette, S., Darro, F., Danguy, A., Salmon, I., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.585 · Cited by 205
Self-citationDeterminants of human astrocytoma migration.
Giese, A., Rief, M. D., Loo, M. A., & Berens, M. E. (1994) · PubMed · Cited by 204
The Extracellular Matrix of Gliomas: Modulation of Cell Function
Gladson, C. L. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199910000-00001 · Cited by 199
Eshleman, J. S., Carlson, B. L., Mladek, A. C., Kastner, B. D., Shide, K. L., & Sarkaria, J. N. (2002) · PubMed · Cited by 198
Taga, T., Suzuki, A., Gonzalez‐Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., & Laug, W. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10265 · Cited by 198
Animal Lectins as Cell Adhesion Molecules
Kaltner, H., & Stierstorfer, B. (1998) · Cells Tissues Organs · doi:10.1159/000046456 · Cited by 196
Khatib, A., Kontogiannea, M., Fallavollita, L., Jamison, B. M., Meterissian, S. H., & Brodt, P. (1999) · PubMed · Cited by 192
Bigner, D. D., Brown, M. T., Friedman, A. H., Coleman, R. E., Akabani, G., Friedman, H. S., Thorstad, W. L., McLendon, R. E., Bigner, S. H., Zhao, X. G., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2202 · Cited by 192
Fuller, G. N., Rhee, C. H., Hess, K. R., Caskey, L. S., Wang, R., Bruner, J. M., Yung, W. K. A., & Zhang, W. (1999) · PubMed · Cited by 189
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 189
Manna, S. K., Sah, N. K., Newman, R. A., Cisneros, A., & Aggarwal, B. B. (2000) · PubMed · Cited by 184
Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Rao, J., & Li, N. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332998 · Cited by 183
Yudowski, G. A., Efendiev, R., Pedemonte, C. H., Katz, A. I., Berggren, P.-O., & Bertorello, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100128297 · Cited by 177
Camby, I., Belot, N., Rorive, S., Lefranc, F., Maurage, C., Lahm, H., Kaltner, H., Hadari, Y., Ruchoux, M., Brotchi, J., et al. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00377.x · Cited by 172
Self-citationStudies on the Mechanism of Resistance to Rapamycin in Human Cancer Cells
Hosoi, H., Dilling, M. B., Liu, L. N., Danks, M. K., Shikata, T., Sekulic, A., Abraham, R. T., Lawrence, J. C., & Houghton, P. J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.815 · Cited by 172
Stein (2000) · doi:10.1054/mehy.1999.0985 · Cited by 171
Relationship between Na+,K+-ATPase and cell attachment
Contreras, R. G., Shoshani, L., Flores-Maldonado, C., Lázaro, A., & Cereijido, M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.23.4223 · Cited by 167
Uhm, J. H., Dooley, N. P., Kyritsis, A. P., Rao, J., & Gladson, C. L. (1999) · PubMed · Cited by 165
Expression of Integrin ανβ3 in Small Blood Vessels of Glioblastoma Tumors
Gladson, C. L. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199611000-00005 · Cited by 162
Amit, S., & Ben‐Neriah, Y. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00096-2 · Cited by 160
Rotblat, B., Niv, H., André, S., Kaltner, H., Gabius, H.-J., & Kloog, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0026 · Cited by 160
Newton, H. B. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.1.105 · Cited by 159
Rorive, S., Belot, N., Decaestecker, C., Lefranc, F., Gordower, L., Micik, S., Maurage, C.-A., Kaltner, H., Ruchoux, M.-M., Danguy, A., et al. (2001) · Glia · doi:10.1002/1098-1136(200103)33:3<241::aid-glia1023>3.0.co;2-1 · Cited by 159
Self-citationMigrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis
Joy, A. M., Beaudry, C. E., Tran, N. L., Ponce, F. A., Holz, D. R., Demuth, T., & Berens, M. E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00712 · Cited by 153
Friedlander, D. R., Zagzag, D., Shif, B., Cohen, H. W., Allen, J. C., Kelly, P. J., & Grumet, M. (1996) · PubMed · Cited by 142
Hyaluronate Receptors Mediating Glioma Cell Migration and Proliferation
Akiyama, Y., Jung, S., Salhia, B., Lee, S., Hubbard, S.-L., Taylor, M. D., Mainprize, T. G., Akaishi, K., van Furth, W. R., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012297132047 · Cited by 139
Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin
Deryugina, E. I., & Bourdon, M. A. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.3.643 · Cited by 136
The role of integrins in the malignant phenotype of gliomas
Joon, H. U. (1999) · Frontiers in bioscience · doi:10.2741/uhm · Cited by 120
Perego, C., Vanoni, C., Massari, S., Raimondi, A., Pola, S., Cattaneo, M. G., Francolini, M., Vicentini, L. M., & Pietrini, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.16.3331 · Cited by 120
Coates, T. D., Rg, W., Hartman, R., & Howard, T. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.4.765 · Cited by 118
Galectin genes: Regulation of expression
Chiariotti, L., Salvatore, P., Frunzio, R., & Bruni, C. B. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014073.23096.3a · Cited by 109
Belot, N., Rorive, S., Doyen, I., Lefranc, F., Bruyneel, E. A., Dedecker, R., Micik, S., Brotchi, J., Decaestecker, C., Salmon, I. J., et al. (2001) · Glia · doi:10.1002/glia.1124 · Cited by 105
Self-citationNagai, S., Washiyama, K., Kurimoto, M., Takaku, A., Endo, S., & Kumanishi, T. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.5.0909 · Cited by 105
Ohnishi, T., Hiraga, S., Izumoto, S., Matsumura, H., Kanemura, Y., Arita, N., & Hayakawa, T. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006532812408 · Cited by 101
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors
NewtonHB (2004) · 中国神经肿瘤杂志 · Cited by 101
Utsuki, S., Sato, Y., Oka, H., Tsuchiya, B., Suzuki, S., & Fujii, K. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015720220602 · Cited by 100
Fuller, G. N., Hess, K. R., Rhee, C. H., Yung, W. K. A., Sawaya, R. A., Bruner, J. M., & Zhang, W. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00427.x · Cited by 96
Weston, B. W., Hiller, K. M., Mayben, J. P., Manousos, G. A., Bendt, K. M., Liu, R., & Cusack, J. C. (1999) · PubMed · Cited by 96
Weaver, K. D., Yeyeodu, S. T., Cusack, J. C., Baldwin, A. S., & Ewend, M. G. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022554824129 · Cited by 95
Srivastava, M., Eidelman, O., Zhang, J., Paweletz, C. P., Caohuy, H., Yang, Q., Jacobson, K. A., Heldman, E., Huang, W., Jozwik, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402030101 · Cited by 93
MECHANICAL ASPECTS OF CELL SHAPE REGULATION AND SIGNALING
Goldmann, W. H. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0857 · Cited by 90
Sreenivasan, Y., Sarkar, A., & Manna, S. K. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.010 · Cited by 87
Autoschizis: a novel cell death
Jamison, J. M., Gilloteaux, J., Taper, H. S., Calderon, P. B., & Summers, J. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00904-8 · Cited by 87
Pietro Riva, G. F. (1999) · Acta Oncologica · doi:10.1080/028418699431438 · Cited by 87
Song, S. W., Fuller, G. N., Khan, A. U., Kong, S., Shen, W., Taylor, E., Ramdas, L., Lang, F. F., & Zhang, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332186100 · Cited by 85
Genetic Markers in Glioblastoma: Prognostic Significance and Future Therapeutic Implications
Hill, C. E., HUNTER, S. B., & Brat, D. J. (2003) · Advances in Anatomic Pathology · doi:10.1097/00125480-200307000-00004 · Cited by 84
Turley, E. A., Austen, L., Moore, D. H., & Hoare, K. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1194 · Cited by 77
Classification of Glioblastoma Multiforme in Adults by Molecular Genetics
Benjamin, R., Capparella, J., & Brown, A. B. (2003) · The Cancer Journal · doi:10.1097/00130404-200303000-00003 · Cited by 76
Shingu, T., Yamada, K., Hara, N., Moritake, K., Osago, H., Terashima, M., Uemura, T., Yamasaki, T., & Tsuchiya, M. (2003) · PubMed · Cited by 74
Galectin-1 Is Overexpressed in Nasal Polyps under Budesonide and Inhibits Eosinophil Migration
Delbrouck, C., Doyen, I., Belot, N., Decaestecker, C., Ghanooni, R., de Lavareille, A., Kaltner, H., Choufani, G., Danguy, A. J., Vandenhoven, G., et al. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780407 · Cited by 72
Owens, G. C., Orr, E. A., DeMasters, B. K., Muschel, R. J., Berens, M. E., & Kruse, C. A. (1998) · PubMed · Cited by 69
Sawyer, T. K. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.1.1 · Cited by 69
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
Takeuchi, H., Kanzawa, T., Kondo, Y., & Kondo, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601605 · Cited by 67
Stenkvist, B. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200108000-00012 · Cited by 67
Wu, C.-J., Chen, Z., Ullrich, A., Greene, M. I., & O’Rourke, D. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203748 · Cited by 66
Regulation of Cortical Actin Networks in Cell Migration
Suetsugu, S., & Takenawa, T. (2003) · International review of cytology · doi:10.1016/s0074-7696(03)29006-9 · Cited by 64
Korr, H. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-250453-2.50008-6 · Cited by 62
Survival pathways meet their end
McCormick, F. P. (2004) · Nature · doi:10.1038/428267a · Cited by 59
Otsuka, G., Nagaya, T., Saito, K., Mizuno, M., Yoshida, J., & Seo, H. (1999) · PubMed · Cited by 54
Cytoplasmic c-Abl provides a molecular ‘Rheostat’ controlling carcinoma cell survival and invasion
Kain, K. H., Gooch, S., & Klemke, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206930 · Cited by 51
Invasion of human glioma Role of extracellular matrix proteins
Rao, J. (1996) · Frontiers in bioscience · doi:10.2741/a135 · Cited by 46
Lefranc, F., James, S., Camby, I., Gaussin, J., Darro, F., Brotchi, J., Gabius, H., & Robert Kiss, A. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.4.0706 · Cited by 41
Self-citationGrowth inhibition of human malignant glioma cells induced by the PI3-K—specific inhibitor
Shingu, T., Yamada, K., Hara, N., Moritake, K., Osago, H., Terashima, M., Uemura, T., Yamasaki, T., & Tsuchiya, M. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.1.0154 · Cited by 39
Animal Lectins: from Initial Description to Elaborated Structural and Functional Classification
Kaltner, H., & Gabius, H. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1267-7_6 · Cited by 29
Ling, J., Liu, Z., Wang, D., & Gladson, C. L. (1999) · Journal of Cellular Biochemistry · Cited by 25
Camby, I., Decaestecker, C., Gordower, L., Dedecker, R., Kacem, Y., Lemmers, A., Siebert, H., Bovin, N. V., Wesseling, P., Danguy, A. J., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.1.75 · Cited by 22
Lefranc, F., Sadeghi, N., Metens, T., Brotchi, J., Salmon, I. J., & Robert Kiss, A. (2003) · Neurosurgery · doi:10.1227/01.neu.0000053366.00088.80 · Cited by 20
Self-citationTargeted Molecular Therapy In Glial Tumors
O’Rourke, D. M. (2004) · Neurosurgery · doi:10.1227/01.neu.0000309633.00854.fd · Cited by 8
Cited by
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Ulrich, T. A., de Juan Pardo, E. M., & Kumar, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4859 · Cited by 901
Galectin-1: a small protein with major functions
Camby, I., Le Mercier, M., Lefranc, F., & Kiss, R. (2006) · Glycobiology · doi:10.1093/glycob/cwl025 · Cited by 893
Self-citationDiffuse glioma growth: a guerilla war
Claes, A., Idema, A. J., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0293-7 · Cited by 636
Metadata
- Authors
- Lefranc, F., Brotchi, J., & Kiss, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-04-01
- Volume
- 23
- Issue
- 10
- Pages
- 2411-2422
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1997773537
- Cited by
- 526
- References
- 116
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.